Tonix Pharmaceuticals
TNXP
#9180
Rank
HK$1.23 B
Marketcap
HK$77.47
Share price
-6.97%
Change (1 day)
-77.93%
Change (1 year)

Earnings for Tonix Pharmaceuticals (TNXP)

Earnings in 2026 (TTM): -HK$1.16 Billion

According to Tonix Pharmaceuticals's latest financial reports the company's current earnings are HK$17.55 Million. In 2025 the company made an earning of -HK$0.96 Billion a decrease over its 2024 earnings that were of -HK$0.59 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Tonix Pharmaceuticals from 2008 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$1.16 Billion21.28%
2025 -HK$0.96 Billion61.37%
2024 -HK$0.59 Billion-36.5%
2023 -HK$0.93 Billion5.61%
2022 -HK$0.88 Billion21.43%
2021 -HK$0.73 Billion82.76%
2020 -HK$0.4 Billion75.22%
2019 -HK$0.23 Billion9.52%
2018 -HK$0.21 Billion23.63%
2017 -HK$0.17 Billion-45.36%
2016 -HK$0.31 Billion-19.09%
2015 -HK$0.38 Billion74.15%
2014 -HK$0.22 Billion153.99%
2013 -HK$85.39 Million
2011 -HK$41.2 Million29538.74%
2010 -HK$0.14 Million-42.58%
2009 -HK$0.25 Million46.05%
2008 -HK$0.17 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Aerie Pharmaceuticals
AERI
-HK$0.19 Billion-84.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Eagle Pharmaceuticals
EGRX
HK$0.27 B-124.14%๐Ÿ‡บ๐Ÿ‡ธ USA